Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-09-17
1992-06-09
Friedman, B. J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3141
Patent
active
051207532
ABSTRACT:
Analogs of 6-mercaptopurine have been found to enhance the detoxification of various electrophilic toxicants in vivo, while having minimal cytotoxicity themselves. This property allows such compounds to act as scavengers for electrophilic toxicants, thereby preventing the cellular damage caused by such toxic agents.
REFERENCES:
MacLeod et al., Proceedings of AACR, vol. 28, (Mar. 1987) "Intracellular Inhibition of Carcinogen-DNA Binding By A Novel, Potential Chemopreventive Agent: 6-Mercaptopurine".
Letter from Michael MacLeod to Beverly Sullivan, Jul. 9, 1987.
Burroughs-Wellcome Internal Memorandum, Sep. 23, 1987.
MacLeod et al., "Inhibition by 6-Mercaptopurine of the Binding of a Benzo(a)pyrene Diol Epoxide to DNA in Chinese Hamster Ovary Cells", 50 Cancer Research 4355-59 (Jul. 15, 1990).
Allan et al., Cancer Research 46, 3569-3573, Jul. 1986, "Protective Effect of Sodium-2-mercaptoethanesulfonate on the Gastrointestinal Toxicity and Lethality of cis-Diamminedichloroplatinum".
Chang et al., Carcinogenesis, vol. 6, No. 8, pp. 1127-1133 (1985), "Effect of Ellagic Acid and Hydroxylated Flavonoids on the Tumorigenicity of Benzo[a]pyrene eand (.+-.)-7.beta.,8.alpha.-dihydroxy-9.alpha.,10.alpha.-epoxy-7,8,9,10-tetrah ydrobenezo[a]pyrene on Mouse Skin and in the Newborn Mouse".
Clarke et al., Cancer Research, vol. 18, pp. 445-456 (May 1958), "Structure-Activity Relationships Among Purines Related to 6-Mercaptopurine".
Lessca, Carcinogenesis, vol. 4, No. 12, pp. 1651-1653 (1983), "Protective Effects of Ellagic Acid and Other Plant Phenols on Benzo[a]pyrene-Induced Neopolasia in Mice".
MacLeod et al., Chemico-Biological Interactions, 63, pp. 279-289 (1987) "Stabilization of a Reactive, Electrophilic Carcinogen, Benzo[a]pyrene Diol Epoxide, by Mammalian Cells".
Miller et al., Cancer, vol. 47, No. 10, pp. 2327-2345 (May 15, 1981), "Searches for Ultimate Chemical Carcinogens and Their Reactions with Cellular Macromolecules".
Plagemann et al., Biochimica et Biophysica Acta, 647, pp. 49-62 (1981), "Facilitated Transport of 6-Mercaptopurine and 6-Thioguanine and Non-Mediated Permeation of 8-Azaguanine in Novikoff Rat Hepatoma Cells and Relationship to Intracellular Phosphoribosylation".
Wood et al., Proceedings of the National Academy of Sciences U.S.A., vol. 79, pp. 5513-5517 (Sep. 1984), "Inhibition of the Mutagenicity of Bay-Region Diol Epoxides of Polycyclic Aromatic Hydrocarbons by Naturally Occurring Plant Phenols: Exceptional Activity of Ellagic Acid".
Zimm et al., Cancer Research, 46, pp. 6286-6289 (Dec. 1986), "Modulation of Thiopurine Cytotoxicity in the HL-60 Cell Line by Physiological Concentrations of Hypoxanthine".
Lo et al., Proceedings of AACR, p. 63 (Mar. 1982), "The Presence of Carrier for Activated Benzo[a]pyrene Metabolite in Human & Mouse Cells".
Kootstra, Carcinogenesis, vol. 3, No. 8, pp. 953-955 (1982), "Formation and Removal of B[a]P Diol Epoxide-DNA Adducts in Human Fibroblasts".
Miller, Cancer Research, vol. 30, No. 3, pp. 559-576 (Mar. 1970), "Carcinogenesis by Chemicals: An Overview".
Hitchings et al., Proceedings of AACR, pp. 395-396 (Mar. 1984), Cain Memorial Award Lecture, "Layer on Layer".
Pelkonen et al., Pharmacological Reviews, vol. 34, No. 2, pp. 189-222 (1982), "Metabolism of Polycyclic Aromatic Hydrocarbons: Etiologic Role in Carcinogenesis".
Pelling et al., Carcinogenesis, vol. 3, No. 10, pp. 1135-1141 (1982), "Comparison of Levels of Benzo[a]pyrene Diol Epoxide Diastereomers Covalently Bound In Vivo to Macromolecular Components of the Whole Epidermis Versus the Basal Cell Layer".
Septi et al., Carcinogenesis, vol. 3, No. 11, pp. 1317-1320 (1982), "Benzo[a]pyrene-DNA Adduct Formation in Target Cells in a Cell-Mediated Mutation Assay".
Tidd et al., Cancer Rese
The U.S. governmentr may own certain rights in this invention pursuant to NIEHS grant No ES03602.
Board of Regents , The University of Texas System
Friedman B. J.
LandOfFree
Chemoprevention of electrophilic damage by mercaptopurine analog does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chemoprevention of electrophilic damage by mercaptopurine analog, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chemoprevention of electrophilic damage by mercaptopurine analog will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1804809